Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.
Daniel Davis, PhD
Advertisement
Daniel Davis, PhD, is a global GMP compliance specialist with Lonza Group Ltd.
Articles by Daniel Davis, PhD
Advertisement
Latest Updated Articles
A Risk-Based Approach to Data IntegrityPublished: July 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
